Demonstrates the development of immunoassays for pesticides in laboratory rodents, highlighting potential for monoclonal antibody applications.
In order to develop immunoassays for pesticides detection, this work describes the choice of three different haptens that present structural similarity to benzimidazole molecule, methods for coupling them with two carrier proteins in order to make them immunogenic, a protocol for immunization of laboratory rodents with hapten-carrier complexes, and the evaluation of the specific antibody responses against haptens using an in-house developed immunoassay. Three carbendazim (methyl 2-benzimidazole-carbamate) derivatives bearing different functional reactive groups (-NH₂, -SH and -COOH), namely 2-(2-Aminoethyl) benzimidazole (AEB),2-Mercaptobenzimidazole (2MB) and 2-Benzimidazole propionic acid (BPA), were coupled to keyhole limpet haemocyanin (KLH) and bovine serum albumin(BSA), respectively, mixed with immuno-adjuvants, and injected four times into Balb/C mice and Wistar rats for induction of specific immune responses.All three chemicals elicited a specific but weak antibodies response upon immunization with hapten-KLH complexes followed by serological testing by indirect ELISA with hapten-BSA complexes, and showed detectabledifferences in antibody titers with regard to number of inoculations, hapten structure and animal species. Whereas the AEB-KLH complex was the strongest, the 2MB-KLH complex was the weakest immunogenic in mice. However, the best animal responders allow the application of technologies for getting monoclonal antibodies against benzimidazoles, which can then be used for immunoassays development.
No takes yet. Share an insight, caveat, or question.
TANASA et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: